Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Heron Therapeutics ( (HRTX) ) has issued an update.
Heron Therapeutics announced the relocation of its corporate headquarters from San Diego, California, to Cary, North Carolina, effective January 1, 2025. The move positions Heron near the Research Triangle Park, facilitating strategic partnerships and expansion within a growing biotech community, aligning with the company’s goals to enhance operations and support its employees.
More about Heron Therapeutics
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on developing and commercializing therapeutic innovations that enhance medical care, particularly for acute care and oncology patients.
YTD Price Performance: -7.06%
Average Trading Volume: 3,174,382
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $240.3M
Find detailed analytics on HRTX stock on TipRanks’ Stock Analysis page.
